BioWorld

July 26, 2002

View Archived Issues

Acusphere's 7th Round Brings $15M For Porous Microparticles

Read More

Innate Immunity Genetic Pathway Runs Caenorhabditis elegans To Homo sapiens, Tracking Evolution

Read More

Hydra Series A Round: $9.3M To Add To Team, Grow Science

Read More

Other News To Note

Read More

Correction

Read More

Anadys Raises $38.3M In Series C To Advance Hepatitis C Products

Anadys - it's research focus neatly split - raised $38.3 million in its Series C round in what could be its last financing before testing the investment waters with an initial public offering. (BioWorld Today) Read More